Skip to main content
ALTO logo

ALTO · Alto Ingredients, Inc.

Track ALTO — free
$4.04 +0.01 (+0.25%) At close · Sep 4
Market Cap
$315.31M
Shares
77.57M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$4.04 Open$4.04 Day$3.98–4.10 52W close$0.92–5.99 Avg vol 30d1.9M Short int5.8M · 7.5% float · 2.4d Short vol53% Last earningsAug 5, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 7

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 9 wks
filed Aug 7, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$943.33M
Trailing 12 months
Net income (TTM)
$51.99M
Trailing 12 months
Revenue growth YoY
+12.5%
Year over year
Operating margin
3.8%
Trailing 12 months
P / E (TTM)
6.0
Trailing earnings · reciprocal yield 16.6%
FCF yield
15.8%
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
+3.3%
Year over year · more shares
Price change (1Y)
+251.3%
Trailing year
Short interest
7.5%
Latest settlement · 2.4 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Weak Sentiment Very Bullish Fundamentals Strong Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg −0%
below
Price vs 50-day avg −15%
below
RSI (14) 41
neutral
MACD trend Positive
52-week position 62%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −8%
trailing
6-month return −6%
trailing
YTD return +40%
this year
Relative strength −21%
vs S&P · 6-mo
Sentiment
smart money
Very Bullish
Trend (MA cross) No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow Accumulating
+31% holders QoQ · +56 funds added
Insider flow Accumulating
Net +$207.5K over 90 days · 0% sells
Short interest Falling
7.51% of float · ▼ -2.7% MoM · 2.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
135 holders — near 3-yr high, broad support
Squeeze score 58
elevated · 0–100
Fundamentals
Strong
Revenue growth −5%
Y/Y
Gross margin 4%
expanding
EPS growth +120%
Y/Y
Free cash flow $8.6M
Valuation P/E 6.1
below peers
Buyback $5.0M
authorized
Balance sheet $56.2M
net debt
Quant / Vol
risk profile
Very High
Volatility 100%
annualized · 1-yr
Max drawdown −34%
past year
ATR 5.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Prior guidance period ended · from the Earnings Call filed Nov 9, 2021
CapEx · fourth quarter $7M – $10M
Gross profit · full year 2021 at least $40M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
1 · 5 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−0% Neutral
Price vs 50-day avg
−15% Bearish
RSI (14)
41 Neutral
MACD trend
Positive Bullish
52-week position
62% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 4 of 6
Trend (MA cross) No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow Accumulating
+31% holders QoQ · +56 funds added
Insider flow Accumulating
Net +$207.5K over 90 days · 0% sells
Short interest Falling
7.51% of float · ▼ -2.7% MoM · 2.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
135 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1 Now $4 · 62% Range high $6
vs 200-day avg 0% vs 50-day avg -15%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ALTO
Alto Ingredients, Inc.
this stock
$315.31M +40.3% -4.9% 6.1 7.5%
LIN
Linde PLC
$220.15B +12.0% +3.0% 30.8 1.1%
AIQUF
L Air Liquide SA /Fi
$126.02B +4.9% 0.0%
SHW
Sherwin Williams Co
$80.66B +3.0% +2.1% 30.7 2.6%
ECL
Ecolab Inc.
$78.29B +6.4% +2.2% 37.5 1.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
135
% held
49.0%
Net QoQ
+3.2M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
101
View
Short & Settlement
Short Interest Falling
Shares short
5.8M
Days to cover
2.4d
Change
-161.1K sh
View
Short Volume
Short vol %
53%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
659
Value
$3.2K
As of
Aug 4, 2026
View
Off-Exchange
Off-exchange %
43.6%
Week of
Jul 27, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$207.5K
Buyers / Sellers
1 / 0
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$917.9M
Net income (FY)
$13.3M
EPS diluted
$0.16
View
Buybacks
Authorized
$5.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 7, 2026
This year
9
View
Earnings & Events
Earnings Calls
Last call
Aug 5, 2026
View

Performance

5D 20D 120D MTD YTD
ALTO -0.7% -8.0% -6.3% +2.0% +40.3%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY -0.9% -7.6% -21.4% +1.6% +27.3%

Capital returns

Buyback program · as of Sep 30, 2024
Authorized
$5.00M
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 778164 CUSIP 021513106 13F (30d) 98 filings 98 filers Visit website Investor relations